Drugs / ALA-3000
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06965569 | Apr → Dec 2025 | — | Alar Pharmaceuticals Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALA-3000 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06965569 ↗ |
| Route | Subcutaneous | “Subcutaneous injection” NCT06965569 ↗ |